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Abstract: 
Objective: To determine the association between C-reactive protein and metabolic syndrome in relation to age gender and 
duration. 
Patients and Methods: This cross sectional descriptive study of six months study was conducted at Liaquat University Hospital 
Hyderabad from 01-July-2013 to 31-Dec-2013. All the patients of 20 to 60 years of age presented with symptoms of metabolic 
syndrome for more than 01 year duration were admitted and evaluated for C-reactive protein. The data was analyzed in SPSS 
and the frequency and percentage was calculated.  
Results: During six month study period, total 142 patients (93 females and 49 males) with metabolic syndrome were evaluated 
for C-reactive protein. Majority of patients were from urban areas 103/142 (72.5%). The mean ±SD for age of patients with 
metabolic syndrome was 42.63±8.82. The mean age ±SD of patient with raised CRP was 45.86±7.21. The mean circumference 
for males and female patients with raised CRP was 49.53±3.73 and 46.89±4.32 while the TG for males and female patients with 
raised CRP was 187.82±4.61 and 191.32±3.84 whereas the HDL-C for males and female patients with raised CRP was 
30.74±2.31 and 26.75±2.51 respectively. The mean ± SD for systolic and diastolic blood pressure of males and female patients 
with raised CRP was 145±3.32 and 100.52±2.61 while the fasting blood glucose level for males and female patients with raised 
CRP was 135.42±2.53 and 146.53±6.54 whereas the CRP for male and female patients with raised CRP was 3.82±1.21 and 
5.9±1.73 respectively. The majority of subjects from 40-49 years of age group with female predominance (p = <0.01) while the 
CRP was raised in 98(69%) patients in relation to age (p=<0.01) and gender (p=<0.01) respectively. Of 98 subjects with raised 
CRP 73 were females and 25 were males (p=0.01).       
Conclusion: The raised CRP was observed in patients with metabolic syndrome.  
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INTRODUCTION:  
Metabolic syndrome includes increase blood sugar 
level and blood pressure, raised serum triglycerides, 
increase waist circumference & decrease high-density 
lipoprotein cholesterol (HDL-C). [1-3] The insulin 
resistance reveals the pathophysiological process and 
responsible for this syndrome and also future 
cardiovascular adverse events. [4,5] The reported 
prevalence for metabolic syndrome in was 46% [6], 
of which hypertension 25%, waist circumference 
30%, reduced HDL-C 89%, hyperglycemia 7% and 
raised triglycerides 14%.[7,8] 
C-reactive protein (CRP) is acute inflammatory 
reactant produced by liver cells while the metabolic 
syndrome labeled as proinflammatory state and 
estimation of C-reactive protein (CRP) can predict 
the future cardiovascular adverse events and diabetes 
mellitus in individuals had metabolic syndrome. [9, 
10] The adipose tissue produces cytokines as 
interleukin 6 (IL-6) that maintains CRP formation by 
liver and modulate its plasma concentration 
according to the inflammatory state in the body. [11-
15] The reported prevalence for raised C-reactive 
protein in metabolic syndrome was 38%.[16] Thus, 
there was no former local study was conducted on 
this topic, there by considering such theme in mind 
the present study was planned to conduct at tertiary 
care hospital Hyderabad so that by early evolution 
the one can reduce the future cardiovascular and  
cerebrovascular adverse events. 
 
PATIENTS AND METHODS:  
By considering the reported prevalence the cross 
sectional study was planned to conducted at tertiary 
care hospital with specific inclusion criteria as the 
individuals diagnosed as case of metabolic syndrome 
for more than one year duration, either gender and of 
20-60 years of age whereas the exclusion criteria 
were the patients with renal & thyroid disorders, 
cardiac failure, liver disorders, malignancy, 
autoimmune disorders, rheumatic fever, infectious 
disorders (infectious mononucleosis, meningitis, 
syphilis and poliomyelitis), rheumatoid and septic 
arthritis, cerebrovascular accident (CVA), acute 
myocardial infarction and the individuals already on 
antibiotic therapy. The patients with symptoms of 
metabolic syndrome were enroll and entered in the 
study after taken the consent for the study. The 
methods for evaluation of component of metabolic 
syndrome were; (1) waist circumference (2) blood 
pressure (3) evaluation of triglycerides, high density 
lipoprotein (HDL) cholesterol and fasting blood 
sugar level, After confirmation of metabolic 
syndrome, the CRP was estimated by taken 2cc 
venous blood sample and sent to laboratory for 
evaluate the CRP levels (the serum CRP >1.0 mg/dL 
was taken as increase / raised / elevated). The data 
was collected while the frequency and percentage 
(%) and mean ±SD were computed in SPSS 21.  
 
RESULTS: 
Total 142 individuals with metabolic syndrome were 
explored for C-reactive protein. 72.5% patients were 
belonged to rural areas while the mean ±SD for age 
(years) of whole population, waist circumferences 
(inches) for male and female population, triglycerides 
(mg/dl) for male and female population, HDL 
(mg/dl) & FBS (mg/dl) for male and female 
population, the systolic (mmHg) and diastolic 
(mmHg) blood pressure in individuals with metabolic 
syndrome was 42.63±8.82 (years), 48.73±5.42 and 
44.83±3.75, 183.53±7.83 and 194.42±5.94, 
28.52±8.64 and 24.73±6.64, 130.52±3.32 and 
148±2.52, 150.62±10.32 and 100.32±5.41. The mean 
±SD of CRP was 5.3±1.32 whereas mean ± SD of 
raised CRP in male and female population was 
3.82±1.21 and 5.9±1.73 respectively. The cross 
tabulation for age, gender and duration of disease are 
demonstrated in Table 1-3. 
 
TABLE 01: THE AGE AND GENDER FOR STUDY POPULATION 
  Gender Total P-value 
  Female Male   
 
 
 
<0.01 
AGE (yrs) 20-29 11 11 22 
  11.8% 22.4% 15.5% 
 30-39 23 17 40 
  24.7% 34.7% 28.2% 
 40-49 52 6 58 
  55.9% 12.2% 40.8% 
 50-60 7 15 22 
  7.5% 30.6% 15.5% 
Total  93 49 142 
  100.0% 100.0% 100.0% 
          *P-value is statistically significant 
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TABLE 02: THE DISTRIBUTION FOR GENDER AND C-REACTIVE PROTEIN 
  CRP Total P-value   
  Raised Normal   
 
 
 
 
 
 
<0.01* 
  
Gender Female 73 20 93   
  74.5% 45.5% 65.5%   
 Male 25 24 49   
  25.5% 54.5% 34.5%   
Total  98 44 142   
  100.0% 100.0% 100.0%   
         *P-value is significant 
 
TABLE 03: THE DISTRIBUTION OF C REACTIVE PROTEIN AND DURATION OF THE DISEASE 
  CRP Total P-value   
  Raised Normal   
 
 
 
0.03* 
  
DURATION (yrs) 1-2 17 10 27   
  17.3% 22.7% 19.0%   
 2-3 50 29 79   
  51.0% 65.9% 55.6%   
 > 3 31 5 36   
  31.6% 11.4% 25.4%   
Total  98 44 142   
  100.0% 100.0% 100.0%   
    *P-value is statistically significant 
 
DISCUSSION:  
The Metabolic syndrome is a risk factor for various 
morbidities including cardiovascular and 
cerebrovascular disorders [17]. 
In current series the CRP was found to be raised in 
69% individuals had metabolic syndrome, of which 
females were seventy three and males were twenty 
five in proportions and are consistent to former 
study.[18] while no any gender difference was 
detected in another study [19]. However, Medina-
Lezama J, et al observed that the syndrome was more 
predominant in female population [20]. The increase 
in the trend of obesity is again might be the major 
risk factor for metabolic syndrome as obesity is again 
common in female population [21-23]. 
The relationship between raised CRP and obesity in 
children and adult population is also studied formerly 
[24, 25]. The previous study was conducted on the 
patients with angina pectoris and revealed that CRP 
was elevated in relation to increase triglycerides, 
body mass index and hypertension [26 while another 
study shown that CRP is directly proportional to 
body mass index, hypertension and raised 
triglycerides and uric acid level [27]. Juhan-Vague I, 
et al [28] observed the increase CRP level in subjects 
with insulin resistance while another study detected 
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that the acute inflammatory markers as CRP and IL-6 
are raised in individuals with metabolic syndrome. 
Yudkin JS et al [30] identified the positive 
association between CRP, TNF-α, IL6 and f  a strong 
relationship of the MS with acute-phase markers, 
including CRP, fibrinogen, IL-6 and TNF-α in 
subjects with metabolic syndrome. In current series 
the 40-49 years age group was predominant and 
related to the former study [31]. In our study the 
female gender was predominant and similar finding 
reported in former literature [32, 33]. 
The metabolic syndrome is related to inflammatory 
process which acts as pathogenetic and plays a major 
role atherothrombotic process and responsible for 
increasing cardiovascular and cerebrovascular 
adverse events. 
 
CONCLUSION: It is concluded that the 
inflammatory marker as C-reactive protein is found 
to be raised in metabolic syndrome (69%) and reveals 
the positive association with female predominance 
(74.4%).  
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